David Bardin

David Bardin has a diverse range of work experience in the pharmaceutical and medical industries. David is currently working at Glaukos Corporation since 2018, serving as the Director of Drug Delivery Innovation. Prior to this, they held positions at the same company as a Senior Manager and Senior Scientist. Before joining Glaukos, David was the Director of Research and Development at University Medical Pharmaceuticals from 2014 to 2018. David also worked as an Assistant Research Specialist at UC Irvine in 2014. David gained experience as a Postdoctoral Fellow at Allergan, Inc. through USC School of Pharmacy from 2013 to 2014. David started their career as a Graduate Student Researcher at UC Irvine from 2009 to 2013. David's early experience includes an engineering internship at Ferring Research Institute from 2007 to 2009.

David Bardin attended The Bishop's School, but no specific degree or field of study is mentioned for this period. From 2005 to 2009, they studied Biomedical Engineering at Duke University and obtained their Bachelor of Science in Engineering. Following that, from 2009 to 2013, David pursued their Doctor of Philosophy and Master's degree in Biomedical Engineering at UC Irvine. Most recently, they completed an Executive MBA at the Quantic School of Business and Technology from 2022 to 2023.